期刊文献+

人外周血单个核细胞来源CD4^+CD25^+调节性T细胞的体外扩增培养及功能研究 被引量:6

In vitro cell expansion and function detection of human peripheral blood mononuclear cell derived CD4^+CD25^+ regulatory T cells
原文传递
导出
摘要 目的建立人外周血单个核细胞来源的CD4+CD25+调节性T细胞体外扩增培养方法 ,研究体外扩增后细胞功能改变。方法 Ficoll-Paque密度梯度分离健康人外周血单个核细胞,免疫磁珠纯化CD4+T细胞,流式分选CD4+CD25+调节性T细胞。用抗人CD3/CD28单抗和IL-2联合刺激CD4+CD25+调节性T细胞,检测其Foxp3、IL-10和TGF-β表达改变。结果人外周血单个核细胞分离纯化得到纯度98%的CD4+CD25+调节性T细胞,Foxp3表达率为95%;使用IL-2加抗CD3/CD28单抗刺激6周后细胞数量可扩增1 000倍;扩增后细胞Foxp3的表达和IL-10、TGF-β的分泌均显著降低。结论本研究成功建立了高纯度大量CD4+CD25+调节性T细胞纯化和体外扩增方法,研究了CD4+CD25+T细胞体外扩增后功能表型的改变。 In this study, we aim to establish an in vitro expansion method for CD4+CD25+ regulatory T cells (Treg) and detect its function. CD4+CD25+reg was separated and purified from peripheral blood mononuclear cell by flow cytometry with 98% purity and 95% of purified cells were Foxp3 positive. The purified CD4+CD25+ Freg was further stimulated in vitro with IL-2 and anti-CD3/CD28 monoclonal antibody for 1 to 6 weeks. Cell proliferation of stimulated Treg was detected by radioactive H3 incorporation assay and a thousandfold increase was found after 6- week cuhure. Furthermore, the expression of Foxp3 and the secretion of IL-10/TGF-β were found significantly lower in stimulated Tregs than those in non-stimulated. In conclusion, this study successfully established an expansion method for CD4+CD25+ Tregs, and Treg lose their Foxp3 marker after in vitro expansion.
作者 周剑 罗邦伟
出处 《免疫学杂志》 CAS CSCD 北大核心 2014年第6期504-507,共4页 Immunological Journal
关键词 外周血单个核细胞 调节性T细胞 FOXP3 体外增殖 免疫调控 Peripheral blood mononuclear cells Regulatory T cell Foxp3 In vitro expansion Immunoregulation
  • 相关文献

参考文献1

二级参考文献12

  • 1Stock P,DeKruyff RH,Umetsu DT.Inhibition of the allergic response by regulatory T cells[J].Curr Opin Allergy Clin Immunol,2006,6(1):12-16.
  • 2Umet su DT,Dekruyff RH.Tmmune dysregulation in asthma[J].Curr Opin Immunol,2006,18(6):727-732.
  • 3Cavassani KA,Campanelli AP,Moreira AP,et al.Systemic and local characterization of regulatory T cells in chronic fungal infection in humans[J].J Imnnmol,2006,177(9):5811-5818.
  • 4Hartl D,Koller B,Mehlhorn AT,et al.Quantitative and functional impairment of pulmonary CD4~+ CD25~(hi) regulatory T cells in pediatric asthma[J].J Allergy Clin Immunol,2007,119(5):1258-1266.
  • 5Lee JH,Yu HH,Wang LC,et al.The levels of CD4~+ CD~25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma[J].J Clin Exp Immunol,2007,148(1):53-63.
  • 6Strickland DH,Stumbles PA,Zosky GR,et al.Reversal of airway hyperresponsiveness by induction of airway mucosal CD4~+ CD~25+ regulstory T cells[J].J Exp Med,2006,203(12):2649-2660.
  • 7Mempel TR,Henrickson SE,Von Andrian UH.T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases[J].Nature,2004,427(6970):154-159.
  • 8Satoguina JS,Weyand E,Larbi J,et al.T regulatory-1 cells induce IgG4 production by B cells:role of IL-10[J].Immunol,2005,174(8):4718-4726.
  • 9Luo ZX,Liu EM,Deng B,et al.Role of Foxp3 expression and CD4~+ CD25~+ regulatory T cells on the pathogenesis of childhood asthma[J].Zhonghua Er Ke Za Zhi,2006,44(4):267-271.
  • 10邢朝品,冯学斌,宋晓冬,张丽霞,刘文波.支气管哮喘大鼠淋巴液中淋巴细胞线粒体跨膜电位变化及地塞米松对其干预的影响[J].滨州医学院学报,2009,32(4):249-252. 被引量:4

共引文献8

同被引文献42

  • 1苏桂平.浅谈血清孕酮测定在预测早期先兆流产预后中的应用价值[J].当代医药论丛,2014,12(2):178-179. 被引量:6
  • 2Raab MS, Podar K, Breitkreutz I, et al. Multiple myeloma[J]. Lancet, 2009, 374(9686): 324-339.
  • 3McCarthy PL, Owzar K, Hofmeister CC, et al. Lenalidomide after stem-cell transplantation for multiple myeloma[J]. N Engl J Med, 2012, 366(19): 1770-1781.
  • 4Duggan ST, Keating GM. Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma[J]. Drugs, 2011, 71(18): 2531-2558.
  • 5Filla MS, Dam P, Rapraeger AC. The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor- 2 binding and activity[J]. J Cell Physiol, 1998, 174(3): 310- 321.
  • 6Harada K, Masuda S, Hirano M, et al. Reduced expression of syndeean-I correlates with histologie dedifferentiation, lymph node metastasis, and poor prognosis in intrahepatic cholangioeareinoma[J]. Hum Pathol, 2003, 34(9): 857-863.
  • 7Maloney DG, Donovan K, Hamblin TJ. Antibody therapy for treatment of multiple myeloma[J]. Semin Hematol, 1999, 36 (1 Suppl 3): 30-33.
  • 8Ragnarsson L, Stromberg T, Wijdenes J, et al. Multiple myeloma eells are killed by syndeean-1-directed superantigen - activated T cells [ J ]. Cancer ImmunolImrnunother, 2001, 50(7): 382-390.
  • 9Couturier O, Faivre Chauvet A, Filippovich IV, et al. Validation of 213Bi-alpha radioimmunotherapy for multiple myeloma[J]. Clin Cancer Res, 1999, 5(10 Suppl): 3165s-3170s.
  • 10Supiot S, Faivre Chauvet A, Couturier O, et al. Comparison of the biologic effects of MA5 and B-B4 monoclonal antibody labeled with iodine-131 and bismuth-213 on multiple myeloma[J]. Cancer, 2002, 94 (4 Suppl): 1202-1209.

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部